Alamar Biosciences To Participate In Upcoming Investor Conferences
- UBS Global Healthcare Conference in Palm Beach Gardens, FL
Fireside chat on Tuesday, November 10 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time
- Citi's 2026 Global Healthcare Conference in Miami, FL
Investor meetings on Wednesday, December 2
Interested parties may access a live and archived webcast of the session on the“Investors” section of the company website at investors.alamarbio.com.
About Alamar Biosciences, Inc.
Alamar is a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Leveraging our proprietary NULISATM technology and the ARGO® HT System, our platform is designed to detect protein biomarkers at extremely low concentrations in blood with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation. We refer to this combination of features as“Precision Proteomics,” and believe it fills a critical gap in the field of advanced proteomics, helping researchers unlock the full spectrum of protein biomarkers across disease states. Learn more at alamarbio.com.
CONTACT: Media Contact Alamar Biosciences, Inc.... Investor Contact Alamar Biosciences, Inc.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment